Report overview
The global Genetic Carrier Screening Service market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Expanded Carrier Screening Service Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Genetic Carrier Screening Service include Clinical Labs, Eurofins Scientific, Fulgent Genetics, Gene by Gene, Illumina, Invitae, MedGenome Labs, My Baby Company and Myriad Genetics, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Genetic Carrier Screening Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Carrier Screening Service. This report contains market size and forecasts of Genetic Carrier Screening Service in global, including the following market information:
Global Genetic Carrier Screening Service Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Genetic Carrier Screening Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genetic Carrier Screening Service Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Genetic Carrier Screening Service Market Segment Percentages, by Type, 2023 (%)
Expanded Carrier Screening Service
Targeted Disease Carrier Screening Service
Global Genetic Carrier Screening Service Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Genetic Carrier Screening Service Market Segment Percentages, by Application, 2023 (%)
Pregnant Woman
Couple
Global Genetic Carrier Screening Service Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Genetic Carrier Screening Service Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genetic Carrier Screening Service revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Genetic Carrier Screening Service revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Clinical Labs
Eurofins Scientific
Fulgent Genetics
Gene by Gene
Illumina
Invitae
MedGenome Labs
My Baby Company
Myriad Genetics
Natera
NxGen MDx, LLC
OPKO Health
Thermo Fisher Scientific
Sonic Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genetic Carrier Screening Service, market overview.
Chapter 2: Global Genetic Carrier Screening Service market size in revenue.
Chapter 3: Detailed analysis of Genetic Carrier Screening Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genetic Carrier Screening Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
